US Pharma MarketingThe FDA cited problems with some of Zoll’s ventilators, automated external defibrillators and electrodes.
Zoll receives FDA warning letter over quality concerns
Zoll receives FDA warning letter over quality concerns is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive